País: Nueva Zelanda
Idioma: inglés
Fuente: Ministry for Primary Industries
canine distemper virus (attenuated); canine parvovirus (attenuated); canine adenovirus type 2 (attenuated)
Schering-Plough Animal Health Limited
canine distemper virus (attenuated), canine adenovirus type 2 (attenuated), canine parvovirus (attenuated)
canine distemper virus (attenuated) 0 vaccine; canine parvovirus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine
Vaccine
ACVM Registered
1987-05-06
NOBIVAC DHP 25 doses – Insert Card and Label A005526 Page 1 of 5 NOBIVAC DHP 23-Nov-22 Insert Card – Front panel RESTRICTED VETERINARY MEDICINE KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY NOBIVAC ® DHP 25 vials of combined live attenuated freeze-dried canine distemper, adenovirus type 2 and parvovirus vaccine. To be reconstituted with Nobivac Diluent or Nobivac Lepto I. ACVM Registration No. A005526. 25 X 1 dose MSD AH Logo Insert Card – Inside panels RESTRICTED VETERINARY MEDICINE KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY NOBIVAC ® DHP DESCRIPTION Nobivac DHP is a live attenuated freeze-dried vaccine offering protection against canine distemper, infectious hepatitis and parvovirus in dogs. Each vial (1 dose when reconstituted) contains: • Canine distemper virus, strain Onderstepoort ≥10 4 TCID 50 • Canine adenovirus type 2, strain Manhattan LPV3 ≥10 4 TCID 50 • Canine parvovirus, strain C154 ≥10 7 TCID 50 The diluent (Nobivac Diluent) is phosphate buffered saline. Nobivac Lepto I (A007832) may be used as diluent. INDICATION Active immunisation of healthy dogs against canine distemper virus, canine adenovirus type 1 and type 2 and canine parvovirus. The puppy programme can be completed from 10 weeks of age and following completion, the components of Nobivac DHP have been shown to protect against canine distemper virus, canine parvovirus and canine adenovirus for at least three years. The onset of immunity is one week following completion of primary vaccination. Nobivac DHP can be used in pregnant bitches. DOSAGE AND ADMINISTRATION Reconstitute each single dose (vial) of the vaccine with one vial (1 mL) of Nobivac Diluent or Nobivac Lepto I vaccine, and administer by subcutaneous injection. When the vaccine is NOBIVAC DHP 25 doses – Insert Card and Label A005526 Page 2 of 5 NOBIVAC DHP 23-Nov-22 reconstituted with Nobivac Diluent the diluent volume can be reduced to a minimum of 0.5 mLs if desired to reduce the volume of the reconstituted vaccine; this applies only t Leer el documento completo